OTTAWA, Ontario–(BUSINESS WIRE)– David Allan, founding Chairman of YM BioSciences and its 13-year CEO is being recognized by the industry in BIOTECanadas naming him as recipient of the Gold Leaf Award for Industry Leadership.
This paper reviews recent literature on bioenergy potentials in conjunction with available biomass conversion technologies. The geographical scope is the European Union, which has set a course for long term development of its energy supply from the current dependence on fossil resources to a dominance of renewable resources. A cornerstone in European energy policies and [...]
Background: The recent discovery of accessory proteins that boost cellulose hydrolysis has increased the economical and technical efficiency of processing cellulose to bioethanol. Oxidative enzymes (e.g. GH61) present in new commercial enzyme preparations have shown to increase cellulose conversion yields. When using pure cellulose substrates it has been determined that both oxidized and unoxidized cellodextrin [...]
Background: A major challenge in the identification and development of superior feedstocks for the production of second generation biofuels is the rapid assessment of biomass composition in a large number of samples. Currently, highly accurate and precise robotic analysis systems are available for the evaluation of biomass composition, on a large number of samples, with [...]
Background: Pretreatment is an essential step in the enzymatic hydrolysis of biomass for bio-ethanol production. The dominant concern in this step is how to decrease the high cost of pretreatment while achieving a high sugar yield. Fungal pretreatment of biomass was previously reported to be effective, with the advantage of having a low energy requirement [...]
For more than 20 years, the main choice for breast implants has been some form of silicone rubber. Recent cancer research suggests nanotechnology may make breast implants safer as an alternative to silicone. Approximately 75 percent of post-mastectomy patients choose some form of breast reconstruction. While no medical device is free of risks, silicone breast [...]
This is the main question that is lurking the minds of biologists for quite some time now because many possibilities for the occurrence of a homosexuality gene exist. During the 1990s many researcher were studying the topic but by the end of the 20th century all such research work was slowed down as many people [...]
The specialty drugs seem to be putting pressure on insurance premiums. These drugs which are being used for treating rare diseases is building pressure on the health insurance and is making it costly for everybody. In some of the cases the cost of the treatment can touch up to $200,000 a year. These drugs are [...]
Is anyway spirituality related to biotechnology? You don’t know the answer but a molecular biologist from Princeton University states that spiritual beliefs plays an important role in deciding whether people accept or reject biotechnology in the field of agriculture or medicine. Though some nations have accepted biotechnology but there are a number of those which [...]
Celebrex from Pfizer has received the approval from federal advisers for marketing it for children suffering from devastated form of arthritis even though there was a split opinion on this issue. Celebrex is a painkiller from the stable of Pfizer. Besides this a recommendation was also made for monitoring the effect of the dug for [...]
Two molecules occurring naturally in blood have been combined by researchers for engineering a molecular complex using solar energy for splitting water into oxygen and hydrogen. Energy is used from the sun for creating hydrogen gas which would serve as an alternative for electrolysis. This is an important development as it could also help in [...]
Researchers have found out that brain cells resulting from human embryonic stem cells resulted in the improvement of conditions of rats suffering from Parkinson but a problem was faced with regards to the eruption of brain tumor. After coming across this problem researchers are working to find a solution for it. This was found out [...]
Researchers from U.K have discovered something which could help in finding out how cystic fibrosis progresses. They have found out that patients suffering from cystic fibrosis had a very high distribution of two proteins in their lungs and airways. These proteins have been found out to play a vital role in the immune system of [...]
Now very soon it would be possible to image blood vessels and destroy malignant cells in a single integrated system. This system has been created by researchers at Stanford University in which nanoparticles have been designed with a dual function and also offers the benefit of being non toxic and water soluble. Consisting of iron [...]
GM crops have received a major setback in Hungary. In a recent development, parliament of Hungary is backing an amendment which poses restrictions on the conditions under which GM crops can be planted. As per the new law a four hundred meter buffer zone would have to be created to avoid cross pollination. Landowners would [...]
NEWARK, Del.–(BUSINESS WIRE)– SDIX (Nasdaq: SDIX – News) – a leading provider of biotechnology-based products and services for a broad range of life science, biotechnology, diagnostic, and food safety applications, expects to release its first quarter 2012 results at approximately 4 p.m. ET on Thursday, May 10, 2012.
NEW YORK, NY–(Marketwire -05/04/12)- www.shinesrooms.com has a handpicked team of market professionals with over 100 years of combined investing experience. Today they are providing members comprehensive research on the Biotechnology industry and are offering free analytical research on Spectrum Pharmaceuticals Inc. (SPPI – News) and Amgen Inc.
RICHMOND, Va.–(BUSINESS WIRE)– The Virginia Biotechnology Association, the statewide trade association for the life sciences industry in the Commonwealth, today announced that long time Executive Director, Mark A. Herzog, will be departing his post effective June 1, 2012.
SUNNYVALE, Calif., May 1, 2012 /PRNewswire/ — Amarantus BioSciences, Inc.
WASHINGTON–(BUSINESS WIRE)– Mark J. Riedy, a Member of the Corporate & Securities Section and Energy & Clean Technology Practice at Mintz, Levin, Cohn, Ferris, Glovsky and Popeo, P.C., will give a plenary address at the World Congress on Biotechnology & Bioprocessing hosted by the Biotechnology Industrial Organization (BIO). The congress is being held April 29-May 2 in Orlando, Florida
